Paper32287331
Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.
Rogy MA and 6 others. Acta Chir Austriaca, 1997. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation. Papers, record 32287331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32287331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8097319 | Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8097319 | PubMed |
| 2 | 8145037 | A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. | J Exp Med | 1994 | https://conductscience.org/library/papers/8145037 | PubMed |
| 3 | 11642817 | The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990. | Hum Gene Ther | 1990 | https://conductscience.org/library/papers/11642817 | PubMed |
| 4 | 8637514 | Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8637514 | PubMed |
| 5 | 1586041 | High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. | Am Rev Respir Dis | 1992 | https://conductscience.org/library/papers/1586041 | PubMed |
| 6 | 2078586 | TNF/TIL human gene therapy clinical protocol. | Hum Gene Ther | 1990 | https://conductscience.org/library/papers/2078586 | PubMed |
| 7 | 1533321 | Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. | Blood | 1992 | https://conductscience.org/library/papers/1533321 | PubMed |
| 8 | 1590703 | Effects of recombinant human interleukin-6 alone and in combination with recombinant interleukin-1 alpha and tumor necrosis factor alpha on antibacterial resistance in mice. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1590703 | PubMed |
| 9 | 2147233 | Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. | Nature | 1990 | https://conductscience.org/library/papers/2147233 | PubMed |
| 10 | 8665205 | Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. | Br J Surg | 1996 | https://conductscience.org/library/papers/8665205 | PubMed |
| 11 | 3317066 | Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. | Nature | 1987 | https://conductscience.org/library/papers/3317066 | PubMed |
| 12 | 3754653 | Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. | Science | 1986 | https://conductscience.org/library/papers/3754653 | PubMed |
| 13 | 8338879 | Immunization with interleukin-2 transfected melanoma cells. A phase I-II study in patients with metastatic melanoma. | Hum Gene Ther | 1993 | https://conductscience.org/library/papers/8338879 | PubMed |
| 14 | 3178487 | Cachectin/TNF production in experimental burns and Pseudomonas infection. | Arch Surg | 1988 | https://conductscience.org/library/papers/3178487 | PubMed |
| 15 | 3384955 | Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3384955 | PubMed |
| 16 | 2299679 | Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2299679 | PubMed |
| 17 | 8632801 | Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. | Nature | 1996 | https://conductscience.org/library/papers/8632801 | PubMed |
| 18 | 1482704 | Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. | Hum Gene Ther | 1992 | https://conductscience.org/library/papers/1482704 | PubMed |
| 19 | 1482709 | A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma. | Hum Gene Ther | 1992 | https://conductscience.org/library/papers/1482709 | PubMed |
| 20 | 8395024 | Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. | Nature | 1993 | https://conductscience.org/library/papers/8395024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32287331
GET https://conductscience.org/api/papers/v1/32287331/references?page=2